A New Adjuvant Combined with Inactivated Influenza Enhances Specific CD8 T Cell Response in Mice and Decreases Symptoms in Swine Upon Challenge

Viral Immunology

Volumn 28, Issue 9, 2015, Pages 524-531

  Bouguyon, Edwige ^a   Goncalves, Elodie ^b   Shevtsov, Alexander ^c   Maisonnasse, Pauline ^a   Remyga, Stepan ^c   Goryushev, Oleg ^c   Deville, Sebastien ^b   Bertho, Nicolas ^a   Ben Arous, Juliette ^b  

^a INRA Institut National de la Recherche Agronomique   (France)

^b SEPPIC   (France)

^c Federal Centre for Animal Health (FGI ARRIAH)   (Russian Federation)

Author keywords

[No Author keywords available]

Indexed keywords

IMMUNOGLOBULIN G1; IMMUNOGLOBULIN G2; IMMUNOLOGICAL ADJUVANT; INACTIVATED VACCINE; SWINE INFLUENZA VACCINE; INFLUENZA VACCINE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIBODY RESPONSE; ARTICLE; CD8+ T LYMPHOCYTE; CELLULAR IMMUNITY; CONTROLLED STUDY; CROSS PROTECTION; DRUG EFFECT; DRUG SAFETY; EMULSION; FEMALE; GRANULOMA; HUMORAL IMMUNITY; IMMUNE RESPONSE; IMMUNOGENICITY; INFLUENZA A VIRUS (H1N1); INJECTION SITE REACTION; MOUSE; NONHUMAN; PORCINE MODEL; SWINE INFLUENZA VIRUS; SYMPTOM; TH1 CELL; VACCINATION; ANIMAL; C57BL MOUSE; DISEASE MODEL; IMMUNOLOGY; ORTHOMYXOVIRIDAE INFECTIONS; PATHOLOGY; PIG;

ADJUVANTS, IMMUNOLOGIC; ANIMALS; CD8-POSITIVE T-LYMPHOCYTES; DISEASE MODELS, ANIMAL; FEMALE; INFLUENZA A VIRUS, H1N1 SUBTYPE; INFLUENZA VACCINES; MICE, INBRED C57BL; ORTHOMYXOVIRIDAE INFECTIONS; SWINE; VACCINES, INACTIVATED;

EID: 84946231110     PISSN: 08828245     EISSN: 15578976     Source Type: Journal    
DOI: 10.1089/vim.2014.0149     Document Type: Article

References (26)

1. Aucouturier J, Dupuis L, and Ganne V. Adjuvants designed for veterinary and human vaccines. Vaccine 2001;19:2666-2672.
2. Belloc C, Dupuis L, Deville S, et al. Evaluation of safety and immune response induced by several adjuvants included in Pasteurella multocida vaccines in chickens. Revue Med Vet 2008;159:371-375.
3. Brookes SM, Nunez A, Choudhury B, et al. Replication, pathogenesis and transmission of pandemic (H1N1) 2009 virus in non-immune pigs. PloS One 2010;5:e9068.
4. Budimir N, Huckriede A, Meijerhof T, et al. Induction of heterosubtypic cross-protection against influenza by a whole inactivated virus vaccine: the role of viral membrane fusion activity. PloS One 2012;7:e30898.
5. Chen Q, Madson D, Miller CL, et al. Vaccine development for protecting swine against influenza virus. Anim Health Res Rev 2012;13:181-195.
6. Choi YK, Goyal SM, and Joo HS. Retrospective analysis of etiologic agents associated with respiratory diseases in pigs. Can Vet J 2003;44:735-737.
7. Cox SJ, Aggarwal N, Statham RJ, et al. Longevity of antibody and cytokine responses following vaccination with high potency emergency FMD vaccines. Vaccine 2003;21:1336-1347.
8. Dar P, Kalaivanan R, Sied N, et al. Montanide ISA 201 adjuvanted FMD vaccine induces improved immune responses and protection in cattle. Vaccine 2013;31:3327-3332.
9. de Jong JC, Smith DJ, Lapedes AS, et al. Antigenic and genetic evolution of swine influenza A (H3N2) viruses in Europe. J Virol 2007;81:4315-4322.
10. Furuya Y. Return of inactivated whole-virus vaccine for superior efficacy. Immunol Cell Biol 2012;90:571-578.
11. Furuya Y, Chan J, Regner M, et al. Cytotoxic T cells are the predominant players providing cross-protective immunity induced by γ-irradiated influenza A viruses. J Virol 2010;84:4212-4221.
12. Garten RJ, Davis CT, Russell CA, et al. Antigenic and genetic characteristics of swine-origin 2009 A(H1N1) influenza viruses circulating in humans. Science 2009;325:197-201.
13. Halbur PG, Paul PS, Frey ML, et al. Comparison of the pathogenicity of two US porcine reproductive and respiratory syndrome virus isolates with that of the Lelystad virus. Vet Pathol 1995;32:648-660.
14. Heegaard PM, Dedieu L, Johnson N, et al. Adjuvants and delivery systems in veterinary vaccinology: current state and future developments. Arch Virol 2011;156:183-202.
15. Huber VC, McKeon RM, Brackin MN, et al. Distinct contributions of vaccine-induced immunoglobulin G1 (IgG1) and IgG2a antibodies to protective immunity against influenza. Clin Vaccine Immunol 2006;13:981-990.
16. Iyer AV, Ghosh S, Singh SN, et al. Evaluation of three "ready to formulate" oil adjuvants for foot-and-mouth disease vaccine production. Vaccine 2000;19:1097-1105.
17. Kyriakis CS, Gramer MR, Barbe F, et al. Efficacy of commercial swine influenza vaccines against challenge with a recent European H1N1 field isolate. Vet Microbiol 2010;144:67-74.
18. Lejal N, Tarus B, Bouguyon E, et al. Structure-based discovery of the novel antiviral properties of naproxen against the nucleoprotein of influenza A virus. Antimicrob Agents Chemother 2013;57:2231-2242.
19. Loeffen WL, Stockhofe N, Weesendorp E, et al. Efficacy of a pandemic (H1N1) 2009 virus vaccine in pigs against the pandemic influenza virus is superior to commercially available swine influenza vaccines. Vet Microbiol 2011;152:304-314.
20. Patil PK, Bayry J, Ramakrishna C, et al. Immune responses of goats against foot-and-mouth disease quadrivalent vaccine: comparison of double oil emulsion and aluminium hydroxide gel vaccines in eliciting immunity. Vaccine 2002;20:2781-2789.
21. Reed SG, Orr MT, and Fox CB. Key roles of adjuvants in modern vaccines. Nature medicine 2013;19:1597-1608.
22. Reeth KV, Brown I, Essen S, et al. Genetic relationships, serological cross-reaction and cross-protection between H1N2 and other influenza A virus subtypes endemic in European pigs. Virus Res 2004;103:115-124.
23. Roux X, Dubuquoy C, Durand G, et al. Sub-nucleocapsid nanoparticles: a nasal vaccine against respiratory syncytial virus. PloS One 2008;3:e1766.
24. Schotsaert M, Ibanez LI, Fiers W, et al. Controlling influenza by cytotoxic T-cells: calling for help from destroyers. J Biomed Biotechnol 2010; 2010:863985.
25. Skountzou I, Quan FS, Jacob J, et al. Transcutaneous immunization with inactivated influenza virus induces protective immune responses. Vaccine 2006;24:6110-6119.
26. Wahl A, Schafer F, Bardet W, et al. HLA class I molecules consistently present internal influenza epitopes. Proc Natl Acad Sci U S A 2009;106:540-545.